1. la,25-Dihydroxy-25-hemisuccinate cholecalciferol has been synthesized and conjugated to bovine serum albumin.
Introduction
Vitamin D 3 is metabolized via 25-hydroxychole calciferol (25-OHD 3 ) to several dihydroxylated products. The most biologically active of these is 1 (1, 2D 3 ], which is considered to be the hormonal form of the vitamin (DeLuca, 1976) . The clinical study of this compound has been hindered by lack of suitable assays. Two radio-ligand assays for l,25-(OH) 2 D 3 have been reported (Brumbaugh, Haussler, Bursac & Haussler, 1974; Eisman, Hamstra, Kream & DeLuca, 1976) , both using a cytoplasmic receptor protein from the chick intestine as the binding protein. However, for technical reasons, wide spread application of these methods has been limited.
An alternative approach, which has been par ticularly successful for steroids, is to develop a radioimmunoassay. In order to make steroids immunogenic they are covalently coupled to protein carriers. Here we report our success in raising antibodies against a conjugate of a hemi succinate of l,25-(OH) 2 D 3 coupled to bovine serum albumin and the use of these antibodies in developing a sensitive radioimmunoassay for 1,25-(OH) 2 D 3 . (Haussler, 1972) . Purification of l,25-[ 3 H](OH) 2 D 3 was achieved by chromatography on Sephadex LH 20 (29 cm x 1 cm column). Before use small quantities (400 000 c.p.m.) of LH 20-purified material were further purified by successive chromatography on silicic acid (0-7 cm x 6 cm column) followed by Celite (0-7 cm x 8 cm). All solvents except diethyl ether were distilled before use.
Materials and methods
the synthesis of 1,25-dihydroxycholesterol described previously (Narwid, Blount, Iacobelli & Uskokovic, 1974) was modified. 25-Hydroxycholesterol-3-acetate was converted into the 25-hemisuccinate derivative by treatment with the acid chloride of methyl succinate. This was sub sequently converted into l,3-diacetate-25-hydroxy-25-hemisuccinate cholesterol and then into the corresponding derivative of 7-dehydrocholesterol. After ultraviolet irradiation and thermal rearrange ment, the acetate groups were removed with alkali to yield l,25-dihydroxy-25-hemisuccinate cholecalciferol.
The hemisuccinate was conjugated with bovine serum albumin by using the mixed anhydride reaction (Erlanger, Borek, Beiser & Lieberman, 1957) . la,25-(OH) 2 -25-Hemisuccinate D 3 (20-7 mg) was dissolved in 0-64 ml of dimethylformamide and mixed with 9 μ\ of tri-n-butylamine and 5 μ\ of isobutyl chlorocarbonate at 0°C; to this was added bovine serum albumin (64 mg) dissolved in a 50% solution of dimethylformamide in water, pH 8. The reaction was performed under N 2 at -10°C and pH 7-5. After 4 h the product was dialysed repeatedly against water at 4°C. The dialysed product was then freeze-dried and stored under N 2 at -20°C. By a comparison of the u.v. spectra of the steroid conjugate with both that of bovine serum albumin and the l,25-(OH) 2 -25-hemisuccinate D 3 (Erlanger et al., 1957) it was estimated that the reaction had yielded a product with approximately 20 hemisuccinate residues per molecule of bovine serum albumin. Adult male rabbits of mixed breed were immunized with either 150 or 450 //g of the l,25-(OH) 2 -25-hemisuccinate-D 3 -bovine serum albumin conjugate emulsified in complete Freund's adjuvant, by injection in mul tiple intradermal sites (Vaitukaitis, Robbins, Nieschlag & Ross, 1971) , with a booster injection 6 weeks after the initial injection. The rabbits were bled 10 days after the last injection and the sera stored at -20° C.
Sera from both immunized and untreated rabbits were tested for binding of l,25-[ 3 H](OH) 2 D 3 in the barbital/acetate buffer system, pH 8-6, as used in the competitive protein-binding assay for 25-OHD 3 (Preece, O'Riordan, Lawson & Kodicek, 1974) . This buffer (containing bovine serum albumin, lg/100 ml) is effective in maintaining 1,25-(OH) 2 D 3 in solution. After a 24 h incubation at 4°C free sterol was separated from bound by treat ment with 100 jul of Dextran-coated charcoal (9 g of Norit GSX charcoal and 0-9 g of Dextran T 20 in 300 ml of barbital/acetate buffer).
In some studies, antisera were treated with 0-4% Rivanol to precipitate cc-globulins (Saifer & Lipkin, 1959) . In this way, the 25-OHD 3 binding protein is precipitated and immune y-globulins are not. (0-046-6 pmol per tube). The cross-reactivity of the antisera was studied by assessing the ability of related sterols to displace the tracer.
Results

Non
A sensitive assay curve was obtained with 1,25-(OH) 2 D 3 and one of the antisera (R7) (Fig. 1) ; the first point on the assay curve (0-046 pmol; 19 pg added) being significantly different from zero {P < 0-01). Scatchard plot analysis showed the maxi mum equilibrium constant for this antibody to be 5-9 x 10' 1/mol. The percentage cross-reactivity (see legend of Fig. 1 ) of the following related sterols was: lct-OHD 3 , 3-8%; 24R,25-(OH) 2 D 3 and 25-OHD 3 , 3%; dihydrotachysterol, 0-45%; D 3 , 013%; D 2 , 0-05%. The calibration curves for all the sera [with the exception of those for 25-OHD 3 and 24,25-(OH) 2 D 3 l were parallel to the l,25-(OH) 2 D 3 curve. With another antiserum tested (R8) the curves for 25-OHD 3 and 24,25-(OH) 2 D 3 were similar to each other and were parallel to the l,25-(OH) 2 D 3 curve, but the crossreactivity of these sterols was only 0-47%. 
Discussion
The radioreceptor assays for l,25-(OH) 2 D 3 have greatly advanced our knowledge of the hormonally active metabolite of vitamin D. However, difficul ties in both the preparation of the binding protein and the procedures used for phase separation, as well as the requirement for extensive purification of plasma extracted hormone, have limited their application. Therefore a radioimmunoassay method using stable specific antibodies, with a simple charcoal separation step, is attractive. A critical step in the development of a radio immunoassay for l,25-(OH) 2 D 3 was selection of a suitable compound to couple to a protein. Con sideration of the pathways used for the chemical synthesis of l,25-(OH) 2 D 3 itself (Narwid et ah, 1974) led us to select l,25-(OH) 2 -25-hemisuccinate D 3 for coupling to bovine serum albumin. We reasoned that the ring structure of this complex (especially the A-ring and the lcr-OH group) would be exposed and the specificity of the antibodies to this part of the molecule would be enhanced, whereas the importance of the side-chain con figuration would be reduced as this would be masked by the adjacent protein in the conjugate.
Our results clearly show that the conjugate is immunogenic, as Fairney, Turner, Baggiolini & Uskokovic (1977) In applying this method to the measurement of l,25-(OH) 2 D 3 in plasma it is necessary to consider the degree of purification required before assay. Factors to be considered include the crossreactivity of 24-and 25-hydroxylated compounds with the antibody, and also the expected con centration of these metabolites in plasma since, for example, 25-OHD 3 circulates at approximately 500-fold the concentration of l,25-(OH) 2 D 3 . The antisera tested so far exhibit sufficient crossreactivity with 25-OHD 3 and 24,25-(OH) 2 D 3 that some preliminary purification of the sample is necessary.
The sensitivity of the assay and the efficiency of the purification procedure used will determine the amount of plasma to be extracted. The assay described here is capable of detecting as little as 20 pg (0-046 pmol) of l,25-(OH) 2 D 3 , which is comparable to the sensitivity of the radioreceptor assays, and entails the extraction of 10-20 ml of plasma. In a preliminary study we have found that, after purification of plasma extracts on Sephadex LH 20 and high-pressure liquid chromatography, this assay can measure l,25-(OH) 2 D 3 in normal subjects, the mean value obtained being 35 pg/ml. are indebted to Dr M. A. Preece and Professor A. E. Kellie for helpful discussion during the course of this work.
